P

Inventor

HOLLINGWORTH GREGORY JOHN

GB27 patents
⚠️ This page may combine multiple inventors who share the name “HOLLINGWORTH GREGORY JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

17 patents
US6172077B1Jan 9, 2001

Spiro-azacyclic derivatives and their use as therapeutic agents

MERCK SHARP & DOHME149 citations97
US6114315ASep 5, 2000

Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety

MERCK SHARP & DOHME26 citations92
US5977104ANov 2, 1999

Use of NK-1 receptor antagonists for treating bipolar disorders

MERCK SHARP & DOHME29 citations92
US5952315ASep 14, 1999

Use of NK-1 receptor antagonists for treating bipolar disorders

MERCK SHARP & DOHME34 citations92
US6518273B1Feb 11, 2003

2-aryl indole derivative as antagonists of tachykinins

MERCK SHARP & DOHME31 citations88
US6476045B2Nov 5, 2002

Azaindole derivatives and their use as therapeutic agents

MERCK SHARP & DOHME16 citations83
US6271230B1Aug 7, 2001

Use of NK-1 receptor antagonists for treating cognitive disorders

MERCK SHARP & DOHME6 citations74
US6071927AJun 6, 2000

Spiro-piperidine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999

Use of NK-1 receptor antagonists for treating movement disorders

MERCK SHARP & DOHME7 citations74
US6100256AAug 8, 2000

Use of NK-1 receptors antagonists for treating schizophrenic disorders

MERCK SHARP & DOHME7 citations73
US6087348AJul 11, 2000

Use of NK-1 receptor antagonists for treating stress disorders

MERCK SHARP & DOHME3 citations63
US5919781AJul 6, 1999

Use of NK-1 receptor antogonists for treating substance use disorders

MERCK SHARP & DOHME5 citations63
US7105507B2Sep 12, 2006

Cyclohexane derivatives and their use as therapeutic agents

MERCK SHARP & DOHME4 citations62
US7442701B2Oct 28, 2008

Amino-heterocycles as VR-1 antagonists for treating pain

MERCK SHARP & DOHME6 citations60
US6096729AAug 1, 2000

Use of NK-1 receptor antagonists for treating amnestic disorders

MERCK SHARP & DOHME0 citations52
US6613765B1Sep 2, 2003

Use of NK-1 receptor antagonists for treating major depressive disorders

MERCK SHARP & DOHME0 citations51
US7253205B2Aug 7, 2007

Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents

MERCK SHARP & DOHME0 citations41

NOVARTIS AG

3 patents

BELLENIE BENJAMIN RICHARD

3 patents

MERCK SHARP

1 patent

MERCK & CO INC

1 patent

BROWN REBECCA ELIZABETH

1 patent

COOKE NIGEL GRAHAM

1 patent